Proteomics at the interface of psychology, gut physiology and dysfunction: an underexploited approach that deserves expansion

References

• Roberts MA, Mutch DM, German JB. Genomics: food and nutrition. Curr. Opin. Biotechnol.12, 516–522 (2001).
   PubMed Web of Science ®Google Scholar
• Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host–microbial relationships in the intestine. Science291, 881–884 (2001).
   PubMed Web of Science ®Google Scholar
• Kussmann M, Affolter M. Proteomic methods in nutrition. Curr. Opin. Clin. Nutr. Metab. Care9, 575–583 (2006).
   PubMedGoogle Scholar
• Kussmann M, Affolter M, Fay LB. Proteomics in nutrition and health. Comb. Chem. High Throughput. Screen.8, 679–696 (2005).
   PubMed Web of Science ®Google Scholar
• Kussmann M, Rezzi S, Daniel H. Profiling techniques in nutrition and health research. Curr. Opin. Biotechnol.19, 83–99 (2008).
   Google Scholar
• Kussmann M, Affolter M. Proteomics at the center of nutrigenomics: comprehensive molecular understanding of dietary health effects. Nutrition25(11–12), 1085–1093 (2009).
   Google Scholar
• Kussmann M, Krause L, Siffert W. Nutrigenomics: where are we with genetic and epigenetic markers for disposition and susceptibility? Nutr. Rev.68(Suppl. 1), S38–S47 (2010).
   Google Scholar
• Mallick P, Kuster B. Proteomics: a pragmatic perspective. Nat. Biotechnol.28, 695–709 (2010).
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Gasteiger, E, Sanchez JC, Appel RD, Hochstrasser DF. Protein identification with sequence tags. Curr. Biol.6, 1543–1544 (1996).
   Google Scholar
• Bantscheff M, Eberhard D, Abraham Y et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol.25, 1035–1044 (2007).
   PubMed Web of Science ®Google Scholar
• Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery? J. Proteome Res.6(9), 3371–3376 (2007).
   PubMed Web of Science ®Google Scholar
• Kussmann M, Panchaud A, Affolter M. Proteomics in nutrition: status quo and outlook for biomarkers and bioactives. J. Proteome. Res.9, 4876–4887 (2010).
   PubMed Web of Science ®Google Scholar
• Hansson J, Panchaud A, Favre L et al. Time-resolved quantitative proteome analysis of in vivo intestinal development. Mol. Cell Proteomics10, M110 (2011).
   Google Scholar
• Wilson ID, Nicholson JK, Castro-Perez J et al. High resolution ‘ultra performance’ liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res.4, 591–598 (2005).
   PubMed Web of Science ®Google Scholar
• Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham-Cooks R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom.40, 430–443 (2005).
   PubMed Web of Science ®Google Scholar
• Johnson JR, Meng FY, Forbes AJ, Cargile BJ, Kelleher NL. Fourier-transform mass spectrometry for automated fragmentation and identification of 5–20 kDa proteins in mixtures. Electrophoresis23, 3217–3223 (2002).
   PubMed Web of Science ®Google Scholar
• Smith RD. Evolution of ESI-mass spectrometry and Fourier-transform ion cyclotron resonance for proteomics and other biological applications. Int. J. Mass Spectrom.200, 509–544 (2000).
   Web of Science ®Google Scholar
• Brock A, Horn DM, Peters EC et al. An automated matrix-assisted laser desorption/ionization quadrupole Fourier-transform ion cyclotron resonance mass spectrometer for ‘bottom-up’ proteomics. Anal. Chem.75, 3419–3428 (2003).
   Google Scholar
• de Godoy LM, Olsen JV, de Souza GA, Li G, Mortensen P, Mann M. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol.7, R50 (2006).
   PubMed Web of Science ®Google Scholar
• Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol.17, 994–999 (1999).
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics3, 1154–1169 (2004).
   PubMed Web of Science ®Google Scholar
• Panchaud A, Hansson J, Affolter MP et al. ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups. Mol. Cell Proteomics7, 800–812 (2008).
   PubMedGoogle Scholar
• Kuster B, Schirle M, Mallick P, Aebersold R. Scoring proteomes with proteotypic peptide probes. Nat. Rev. Mol. Cell Biol.6, 577–583 (2005).
   PubMed Web of Science ®Google Scholar
• Mallick P, Schirle M, Chen SS et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol.25, 125–131 (2007).
   PubMed Web of Science ®Google Scholar
• Panchaud A, Affolter M, Moreillon P, Kussmann M. Experimental and computational approaches to quantitative proteomics: status quo and outlook. J. Proteomics71, 19–33 (2008).
   PubMed Web of Science ®Google Scholar
• Cans C, Mangano R, Barila D, Neubauer G, Superti-Furga G. Nuclear tyrosine phosphorylation: the beginning of a map. Biochem. Pharmacol.60, 1203–1215 (2000).
   PubMedGoogle Scholar
• Kocher T, Superti-Furga G. Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat. Methods4, 807–815 (2007).
   PubMed Web of Science ®Google Scholar
• Oppermann FS, Gnad F, Olsen JV et al. Large-scale proteomics analysis of the human kinome. Mol. Cell Proteomics8, 1751–1764 (2009).
   PubMedGoogle Scholar
• Trelle MB, Jensen ON. Functional proteomics in histone research and epigenetics. Expert. Rev. Proteomics4(4), 491–503 (2007).
   PubMed Web of Science ®Google Scholar
• Hansson J, Bosco N, Favre L et al. Influence of gut microbiota on mouse B2 B cell ontogeny and function. Mol. Immunol.48, 1091–1101 (2011).
   PubMed Web of Science ®Google Scholar
• Framson PE, Cho DH, Lee LY, Hershberg RM. Polarized expression and function of the costimulatory molecule CD58 on human intestinal epithelial cells. Gastroenterology116, 1054–1062 (1999).
   Google Scholar
• Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J. Immunol.174, 4453–4460 (2005).
   PubMed Web of Science ®Google Scholar
• Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology124, 993–1000 (2003).
   PubMed Web of Science ®Google Scholar
• Yang SK, Eckmann L, Panja A, Kagnoff MF. Differential and regulated expression of C–X–C, C–C, and C-chemokines by human colon epithelial cells. Gastroenterology113, 1214–1223 (1997).
   PubMed Web of Science ®Google Scholar
• Canny G, Colgan SP. Events at the host–microbial interface of the gastrointestinal tract. I. Adaptation to a microbial world: role of epithelial bactericidal/permeability-increasing protein. Am. J. Physiol. Gastrointest. Liver Physiol.288, G593–G597 (2005).
   Google Scholar
• Wehkamp J, Fellermann K, Herrlinger KR, Bevins CL, Stange EF. Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Pract. Gastroenterol. Hepatol.2, 406–415 (2005).
   PubMedGoogle Scholar
• Meddings JB. Intestinal permeability in Crohn’s disease. Aliment. Pharmacol. Ther.3, 47–53 (1997).
   Google Scholar
• James SP. Prototypic disorders of gastrointestinal mucosal immune function: Celiac disease and Crohn’s disease. J. Allergy Clin. Immunol.115, 25–30 (2005).
   Google Scholar
• Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol.102, 448–455 (1995).
   PubMed Web of Science ®Google Scholar
• Farrell RJ, LaMont JT. Microbial factors in inflammatory bowel disease. Gastroenterol. Clin. North Am.31, 41–62 (2002).
   Google Scholar
• Shanahan F. The host–microbe interface within the gut. Best. Pract. Res. Clin. Gastroenterol.16, 915–931 (2002).
   PubMed Web of Science ®Google Scholar
• Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut53(Suppl. 5), V1–V16 (2004).
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin. Infect. Dis.38, 1690–1699 (2004).
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res.622, 70–83 (2007).
   PubMed Web of Science ®Google Scholar
• Roy N, Barnett M, Knoch B, Dommels Y, McNabb W. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res.622, 103–116 (2007).
   PubMedGoogle Scholar
• Holtmann MH, Krummenauer F, Claas C et al. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig. Dis. Sci.51, 1516–1524 (2006).
   PubMed Web of Science ®Google Scholar
• Isaacs KL, Sartor RB. Treatment of inflammatory bowel disease with antibiotics. Gastroenterol. Clin. North Am.33, 335–345 (2004).
   PubMed Web of Science ®Google Scholar
• Sartor RB. Review article: how relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment. Pharmacol. Ther.11(Suppl. 3), 89–96 (1997).
   Google Scholar
• Seksik P, Rigottier-Gois L, Gramet G et al. Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut52, 237–242 (2003).
   PubMed Web of Science ®Google Scholar
• Furrie E, Macfarlane S, Kennedy A et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut54, 242–249 (2005).
   PubMed Web of Science ®Google Scholar
• Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature389, 737–742 (1997).
   PubMed Web of Science ®Google Scholar
• Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev.182, 190–200 (2001).
   PubMed Web of Science ®Google Scholar
• Strober W, Nakamura K, Kitani A. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J. Clin. Invest.107, 667–670 (2001).
   Google Scholar
• Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J. Exp. Med.192, 41–52 (2000).
   PubMed Web of Science ®Google Scholar
• Kussmann M, Blum S. OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers. Endocr. Metab. Immune Disord. Drug Targets7, 271–287 (2007).
   PubMedGoogle Scholar
• Danielsen M, Thymann T, Jensen BB, Jensen ON, Sangild PT, Bendixen E. Proteome profiles of mucosal immunoglobulin uptake in inflamed porcine gut. Proteomics6, 6588–6596 (2006).
   PubMedGoogle Scholar
• Danielsen M, Hornshoj H, Siggers RH, Jensen BB, van Kessel AG, Bendixen E. Effects of bacterial colonization on the porcine intestinal proteome. J. Proteome Res.6, 2596–2604 (2007).
   Web of Science ®Google Scholar
• Jiang P, Sangild PT, Siggers RH, Sit WH, Lee CL, Wan JM. Bacterial colonization affects the intestinal proteome of preterm pigs susceptible to necrotizing enterocolitis. Neonatology99, 280–288 (2011).
   Google Scholar
• Thébault S, Deniel N, Galland A et al. Human duodenal proteome modulations by glutamine and antioxidants. Proteomics Clin. Appl.4, 325–336 (2010).
   Google Scholar
• Langley JN. Observations on denervated muscle. J. Physiol.50, 335–344 (1916).
   PubMedGoogle Scholar
• Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut45(Suppl. 2), II6–II16 (1999).
   Google Scholar
• Hansen MB. The enteric nervous system I: organisation and classification. Pharmacol. Toxicol.92, 105–113 (2004).
   Google Scholar
• Hansen MB. The enteric nervous system III: a target for pharmacological treatment. Pharmacol. Toxicol.93, 1–13 (2003).
   PubMedGoogle Scholar
• Hansen MB. The enteric nervous system II: gastrointestinal functions. Pharmacol. Toxicol.92, 249–257 (2003).
   PubMedGoogle Scholar
• Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology122, 2032–2048 (2002).
   PubMed Web of Science ®Google Scholar
• Barreau F, Ferrier L, Fioramonti J, Bueno L. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr. Res.62, 240–245 (2007).
   PubMedGoogle Scholar
• Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res.122, 81–103 (2000).
   PubMed Web of Science ®Google Scholar
• Coutinho SV, Plotsky PM, Sablad M et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am. J. Physiol. Gastrointest. Liver Physiol.282, G307–G316 (2002).
   PubMed Web of Science ®Google Scholar
• Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut57, 582–590 (2008).
   PubMed Web of Science ®Google Scholar
• Hyland NP, Julio-Pieper M, O’Mahony SM et al. A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? Gut58, 31029–31030 (2009).
   Google Scholar
• Choi YS, Choe LH, Lee KH. Recent cerebrospinal fluid biomarker studies of Alzheimer’s disease. Exp. Rev. Proteomics7(6), 919–929 (2010).
   PubMed Web of Science ®Google Scholar
• Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, Glucksman MJ. Neuroproteomics: expression profiling of the brain’s proteomes in health and disease. Neurochem. Res.29, 1317–1331 (2007).
   Google Scholar
• Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer’s disease. Brain Res. Mol. Brain Res.118, 140–146 (2003).
   PubMedGoogle Scholar
• Dayon L, Turck N, Garcia-Berrocoso T et al. Brain extracellular fluid protein changes in acute stroke patients. J. Proteome Res.10(3), 1043–1051 (2011).
   PubMed Web of Science ®Google Scholar
• Husi H, Grant SGN. Proteomics of the nervous system. Trends Neurosci.24, 259–266 (2001).
   PubMed Web of Science ®Google Scholar
• Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait BT. The yeast nuclear pore complex: composition, architecture and transport mechanism. J. Cell Biol.148, 635–651 (2000).
   PubMed Web of Science ®Google Scholar
• Robinson RA, Lange MB, Sultana R et al. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein (APP). Neuroscience17, 207–222 (2011).
   Google Scholar
• Ginsberg SD. Expression profile analysis of brain aging. In: Brain Aging: Models, Methods and Mechanisms. Riddle DR (Ed.). Frontiers in Neuroscience, CRC Press, FL, USA (2007).
   Google Scholar
• Marvin-Guy L, Lopes LV, Affolter M et al. Proteomics of the rat gut: analysis of the myenteric plexus-longitudinal muscle preparation. Proteomics5, 2561–2569 (2005).
   Google Scholar
• Lopes LV, Marvin-Guy LF, Fuerholz A et al. Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life. J. Proteomics71, 80–88 (2008).
   Google Scholar
• Camilleri M, Heading R, Thompson WG. Consensus report: clinical perspectives, mechanisms, diagnosis and management if Irritable Bowel Syndrome. Aliment. Pharmacol. Ther.16, 1407–1430 (2004).
   Google Scholar
• Atkinson RJ, Hunter JO. Role of diet and bulking agents in the treatment of IBS. In: Irritable Bowel Syndrome. Camilleri M, Spiller RC, Saunders WB (Eds). Elsevier Sciences Ltd., Edinburgh, Scotland, UK, 141–150 (2002).
   Google Scholar
• Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology126, 693–702 (2004).
   PubMed Web of Science ®Google Scholar
• Barbara G, Wang B, Stanghellini V et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology132, 26–37 (2007).
   PubMed Web of Science ®Google Scholar
• Soderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am. J. Physiol. Gastrointest. Liver Physiol.280, G7–G13 (2001).
   PubMed Web of Science ®Google Scholar
• Nanni P, Levander F, Roda G, Caponi A, James P, Roda A. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn’s disease patients. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.877, 3127–3136 (2009).
   PubMedGoogle Scholar
• Kang L, Yang ZL, Liu W et al. Serum proteomic variation study in patients with Crohn disease. Zhonghua Wei Chang Wai Ke Za Zhi11, 266–269 (2008).
   Google Scholar
• Kang L, Yang ZL, Wang L et al. Expression of CD45 in the serum of patients with Crohn’s disease. Nan Fang Yi Ke Da Xue Xue Bao29, 259–263 (2009).
   Google Scholar
• Barcelo-Batllori S, André M, Servis C et al. Proteomic analysis of cytokine-induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics2, 551–560 (2002).
   PubMed Web of Science ®Google Scholar
• Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics6, 5322–5331 (2006).
   PubMed Web of Science ®Google Scholar
• Lomnytska M, Lukiyanchuk V, Hellman U, Souchelnytskyi S. Transforming growth factor-β1-regulated proteins in human endothelial cells indentified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics4, 995–1006 (2004).
   Google Scholar
• Nanni P, Mezzanotte L, Roda G et al. Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometry. J. Proteomics72, 865–873 (2009).
   Google Scholar
• Meuwis MA, FilletM, Lutteri L et al. Proteomics for prediction and characterization of response to infliximab in Crohn’s disease: a pilot study. Clin. Biochem.41, 960–967 (2008).
   PubMed Web of Science ®Google Scholar
• Hatsugai M, Kurokawa MS, Kouro T et al. Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn’s disease. J. Gastroenterol.45, 488–500 (2010).
   PubMed Web of Science ®Google Scholar
• Kaakoush NO, Man SM, Lamb S et al. The secretome of Campylobacter concisus. FEBS J.277, 1606–1617 (2010).
   Google Scholar
• Chen CS, Sullivan S, Anderson T et al. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Mol. Cell Proteomics8, 1765–1776 (2009).
   PubMed Web of Science ®Google Scholar
• Shih TC, Hsieh SY, Hsieh YY et al. Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis. World J. Gastroenterol.14, 1759–1767 (2008).
   Google Scholar
• Shkoda A, Werner T, Daniel H, Gunckel M, Rogler G, Haller D. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J. Proteome Res.6, 1114–1125 (2007).
   Google Scholar
• Kanmura S, Uto H, Numata M et al. Human neutrophil peptides 1–3 are useful biomarkers in patients with active ulcerative colitis. Inflamm. Bowel Dis.15, 909–917 (2009).
   Google Scholar
• Ding Y, Lu B, Chen D, Meng L, Shen Y, Chen S. Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics10, 2620–2630 (2010).
   PubMed Web of Science ®Google Scholar